Anxiety Disorders at AAPP 2027 Annual Meeting

4 sessions on anxiety disorders · April 4–7, 2027, Louisville, KY. Compare anxiety disorders at other meetings →

Monday, April 5

  • 08:00–09:00 · Lecture · Clinical Application Series

    Mental Health Care in Oncology: Highlighting a Lived Experience

    Kelly N. Gable

    A session drawing on a patient's lived experience and current evidence to examine anxiety, depression and distress in people with cancer. It covers barriers to integrated mental health care and the psychiatric pharmacist's role in supporting patients, including menopause related to cancer treatment.

    Collaborative & Integrated Care · Depression · Medical Comorbidity & C-L Psychiatry

  • 09:15–10:15 · Lecture

    When Panic Persists: Navigating Difficult to Treat Panic Disorder

    Sarah T. Thomason

    Reviews pharmacologic and nonpharmacologic options for panic disorder that persists after first-line treatment, including emerging strategies and how to apply evidence to complex cases. Covers monitoring treatment response and safety.

    Pharmacogenomics & Precision Psychiatry · Treatment-Resistant Depression

Tuesday, April 6

  • 09:15–10:15 · Symposium · Clinical Application Series

    Measurement-Based Care: From Scores to Action (PHQ-9 and GAD-7)

    Dana Chiulli · Richard Silvia · Caitlin McCoyd · Lacey J. Vann

    A small-group, case-based workshop on interpreting PHQ-9 and GAD-7 scores and using them to guide treatment and follow-up decisions. Participants practice tracking score changes over time with facilitator feedback. In-person only and not recorded.

    Depression · Measurement-Based Care & Diagnosis

  • 14:50–15:50 · Lecture

    Testosterone Across the Male Lifespan and Implications for Mental Health

    Jeremy Daniel

    Covers how testosterone changes across a man's life and how it relates to mood, anxiety and cognition. Reviews neurotransmitter mechanisms, patient selection for screening, and the benefits, limits and risks of testosterone replacement therapy.

    Depression · Neuroscience & Mechanisms · Medical Comorbidity & C-L Psychiatry

Other topics at this meeting

Drug Interactions & Safety 5Practice, Policy & Workforce 5Medical Comorbidity & C-L Psychiatry 5Antipsychotic Prescribing 4Collaborative & Integrated Care 4Education & Training 4Schizophrenia & Psychosis 4Deprescribing & Polypharmacy 3Depression 3Measurement-Based Care & Diagnosis 3Pharmacogenomics & Precision Psychiatry 3Child & Adolescent 2

Full program overview →